Table 2.
Characteristics of calcium-regulating hormones, bone markers, and BMD values.
| Variables | DM1 (n = 98) | DM2 (n = 137) | Control (n = 82) |
|---|---|---|---|
| PTH, ng/L | 51.16 (47.17–55.13)∗ | 51.69 (48.82–54.56)∗ | 45.09 (40.38–49.79) |
| CT, ng/L | 12.07 (9.75–14.38)∗ | 10.23 (8.48–11.62)∗ | 5.5 (4.19–6.84) |
| 25 (OH) D, nmol/L | 60.12 (53.21–67.04)∗ | 62.69 (57.35–68.08)∗ | 75.9 (67.26–84.51) |
| ALP, IU/L | 118.3 (110.1–126.4) | 122.2 (116.2–128.1) | 123.5 (113.8–133.2) |
| P1NP, ng/mL | 40.58 (37.18–43.98)∗ | 42.08 (39.81–44.35) | 47.09 (42.82–51.35) |
| b-CTX, ng/mL | 0.525 (0.468–0.582)∗ | 0.495 (0.456–0.533)∗ | 0.424 (0.383–0.466) |
| Т-score (L1–L4) | −2.04 (−2.3; −1.7)∗ | −1.08 (−1.3; −0.8)∗ | −0.73 (−1.1; −0.3) |
| Т-score (prox.) | −1.44 (−1.7; −1.1)∗ | −0.95 (−1.2; −0.7)∗ | −0.49 (−0.8; −0.1) |
| Т-score (FN) | −1.68 (−1.9; −1.3)∗ | −1.12 (−1.3; −0.8)∗ | −0.64 (−1.0; −0.2) |
∗ p < 0.05 compared with the control group data.